☰

Frank G. Bottone, Ph.D. - Publications

Affiliations: 
2005 North Carolina State University, Raleigh, NC 
Area:
Nutrition, Molecular Biology
Tree Info Similar researchers PubMed Report error

11 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2011 Bottone FG, Alston-Mills B. The dietary compounds resveratrol and genistein induce activating transcription factor 3 while suppressing inhibitor of DNA binding/differentiation-1. Journal of Medicinal Food. 14: 584-93. PMID 21554132 DOI: 10.1089/Jmf.2010.0110  0.693
2007 Lee CR, Bottone FG, Krahn JM, Li L, Mohrenweiser HW, Cook ME, Petrovich RM, Bell DA, Eling TE, Zeldin DC. Identification and functional characterization of polymorphisms in human cyclooxygenase-1 (PTGS1). Pharmacogenetics and Genomics. 17: 145-60. PMID 17301694 DOI: 10.1097/01.Fpc.0000236340.87540.E3  0.395
2005 Moon Y, Bottone FG, McEntee MF, Eling TE. Suppression of tumor cell invasion by cyclooxygenase inhibitors is mediated by thrombospondin-1 via the early growth response gene Egr-1. Molecular Cancer Therapeutics. 4: 1551-8. PMID 16227405 DOI: 10.1158/1535-7163.Mct-05-0213  0.599
2005 Kim JS, Baek SJ, Bottone FG, Sali T, Eling TE. Overexpression of 15-lipoxygenase-1 induces growth arrest through phosphorylation of p53 in human colorectal cancer cells. Molecular Cancer Research : McR. 3: 511-7. PMID 16179498 DOI: 10.1158/1541-7786.Mcr-05-0011  0.479
2005 Bottone FG, Moon Y, Alston-Mills B, Eling TE. Transcriptional regulation of activating transcription factor 3 involves the early growth response-1 gene. The Journal of Pharmacology and Experimental Therapeutics. 315: 668-77. PMID 16079301 DOI: 10.1124/Jpet.105.089607  0.681
2005 Bottone FG, Moon Y, Kim JS, Alston-Mills B, Ishibashi M, Eling TE. The anti-invasive activity of cyclooxygenase inhibitors is regulated by the transcription factor ATF3 (activating transcription factor 3). Molecular Cancer Therapeutics. 4: 693-703. PMID 15897233 DOI: 10.1158/1535-7163.Mct-04-0337  0.698
2005 Ishibashi M, Bottone FG, Taniura S, Kamitani H, Watanabe T, Eling TE. The cyclooxygenase inhibitor indomethacin modulates gene expression and represses the extracellular matrix protein laminin gamma1 in human glioblastoma cells. Experimental Cell Research. 302: 244-52. PMID 15561105 DOI: 10.1016/J.Yexcr.2004.09.021  0.598
2004 Nixon JB, Kim KS, Lamb PW, Bottone FG, Eling TE. 15-Lipoxygenase-1 has anti-tumorigenic effects in colorectal cancer. Prostaglandins, Leukotrienes, and Essential Fatty Acids. 70: 7-15. PMID 14643174 DOI: 10.1016/J.Plefa.2003.06.001  0.46
2004 Bottone FG, Martinez JM, Alston-Mills B, Eling TE. Gene modulation by Cox-1 and Cox-2 specific inhibitors in human colorectal carcinoma cancer cells. Carcinogenesis. 25: 349-57. PMID 14633654 DOI: 10.1093/Carcin/Bgh016  0.676
2003 Bottone FG, Martinez JM, Collins JB, Afshari CA, Eling TE. Gene modulation by the cyclooxygenase inhibitor, sulindac sulfide, in human colorectal carcinoma cells: possible link to apoptosis. The Journal of Biological Chemistry. 278: 25790-801. PMID 12734198 DOI: 10.1074/jbc.M301002200  0.582
2002 Bottone FG, Baek SJ, Nixon JB, Eling TE. Diallyl disulfide (DADS) induces the antitumorigenic NSAID-activated gene (NAG-1) by a p53-dependent mechanism in human colorectal HCT 116 cells. The Journal of Nutrition. 132: 773-8. PMID 11925476 DOI: 10.1093/Jn/132.4.773  0.497
Show low-probability matches.